Portada     Correo     Artículos     Algunas Referencias      Reportes     English  

Algunas referencias científicas para profundizar en el estudio de la SEROPOSITIVIDAD en las mal llamadas “Pruebas para VIH”


(Actualizado marzo de 2011)

Preparado por Roberto Giraldo, M.D.

En vista de que ocasionalmente circulan en el grupo de Monarcas-Perú mensajes afirmando, sugiriendo o insinuando que ser seropositivo, es decir, el resultar positivo en las mal llamadas “Pruebas para VIH” no tiene ningún significado, envié el 17 de febrero del presente ano el siguiente mensaje al grupo, en el cual afirme una vez mas mis convicciones científicas:

Queridos amigos de Monarcas-Perú (17 de febrero de 2011):

...el hecho de non existir el VIH, de ninguna manera puede interpretarse como que la seropositividad no indica nada. La seropositividad indica muchas cosas como deterioro y fatiga inmunológica, desequilibrios fisiológicos y bioquímicos, intoxicación, oxidación, acidosis interna, bloqueos energéticos, desequilibrios emocionales y un riesgo de enfermar de algo incluso de SIDA. El VIH no existe, pero el SIDA si. Indiscutiblemente resultar positivo en esas pruebas (seropositividad) es un riesgo para SIDA, claro no absoluto, pero es anticientífico y peligroso negar ese riesgo.

Los seropositivos deben tomar precauciones por el resto de sus vidas como se explica en detalle en mis articulas y libros y principalmente en mi ultimo libro: "Usando nuestra farmacia interior para prevenir y curar el SIDA". Los seropositivos que viven una vida sana y larga, toman precauciones orgánicas, pero sobre todo emocionales y espirituales...

No es sano, del hecho de que el VIH no exista, concluir que no se deben tomar precauciones...... Es mas fácil negar todo pero riesgoso y por eso cuando algunos seropositivos escuchas lo que estoy diciendo aquí enfurecen......

Cordialmente,
Roberto Giraldo, M.D.

Como lo anticipé, algunos pocos enfurecieron y respondieron (públicamente) con insultos personales y adjetivos descalificativos. A estos ataques desmedidos, he respondido con explicaciones especialmente para personas seropositivas, Mis explicaciones han ido con varios listados de referencias científicas que sustentan mis puntos de vista y mis afirmaciones, para aquellos que deseen profundizar en este importante asunto.

El presente documento es un listado mas completo de referencias científicas, que constituyen las bases y el fundamento de mis afirmaciones, las cuales reitero hoy.

Sin embargo, como sé que para muchas personas será difícil conseguir y estudiar todas estas referencias, sugiero entonces a los lectores del foro de Monarcas Perú, estudiar simplemente los siguientes artículos míos que pueden ser bajados gratuitamente de mi página del Internet y que pueden ser entendidos fácilmente:

a) “Las pruebas para VIH no pueden diagnosticar la infección VIH” (2006). Todo este artículo es importante pero especialmente el capítulo 7: El verdadero significado de ser "VIH-positivo" o "seropositivo", debe ser leído con particular cuidado.

b) “Terapia nutricional para el tratamiento y la prevención del SIDA: Bases científicas” (2003). En este estudiar con especial atención el capitulo 6: “Estrés oxidativo y VIH/SIDA” y el capítulo 7: “Deficiencias nutricionales y de antioxidantes en la patogénesis del SIDA”.

c) “Tratamiento y prevención del SIDA: Guía de principios básicos para una alternativa no tóxica, efectiva y barata” (2002). En este es fundamental leer cuidadosamente el capítulo 3: “Evitar exposición a agentes estresantes inmunológicos”.

d) También les sugiero estudiar mi último libro, que es pequeño y muy fácil de leer: “Usando nuestra farmacia interior para prevenir y curar el SIDA” (2009), especialmente el numeral 3.4. “Estrés oxidativo y SIDA” del capítulo 3 sobre “Las verdaderas causas del SIDA” y el numeral 5.4. “El “VIH” es simplemente una respuesta del cuerpo al estrés”, del capítulo 5 sobre “Las pruebas para VIH no son adecuadas”.

OBSERVACIÓN: Las personas que estudien esta información científica, deben tener en mente que aquello que los ortodoxos defensores del VIH, llaman Infección VIH (“HIV-Infection”) es lo que yo acostumbro denominar seropositividad (“Seropositivity”). Además, aquellos que no entiendan inglés sugiero pidan ayuda a quien hable inglés para estudiar esta valiosísimas lista de publicaciones científicas. El solo hecho de leer solamente los títulos de estas investigaciones les permitirá comprender cómo la información científica existente corrobora la idea de que la seropositividad sí tiene un significado importante y que aquellos seropositivos que deseen tener una vida larga y saludable deberán siempre tener precauciones simples.

CONTENIDO:

1) Referencias científicas sobre inmunología nutricional. Micronutrientes y activación inmunológica, agentes oxidantes, antioxidantes y las respuestas del sistema inmune. Intoxicación y oxidación del sistema inmunológico.

2) Referencias científicas sobre la existencia de deficiencias nutricionales y de agentes antioxidantes en personas seropositivas.

3) Referencias científicas que advierten que el progreso de seropositivos a SIDA, puede ser debido a deficiencias nutricionales y de agentes antioxidantes.

4) Referencias científicas que sustentan la posibilidad real de que lo que se conoce como “transmisión del SIDA”, es decir el tornarse seropositivo, pueda ser explicado, en gran parte, por deficiencias nutricionales y de agentes antioxidantes.

5) Referencias científicas que sustentan la posibilidad real de explicar la seropositividad y el SIDA con estrés oxidativo. Algunas medidas de prevención y tratamiento.

1) REFERENCIAS CIENTIFICAS SOBRE INMUNOLOGIA NUTRICIONAL, MICRONUTRIENTES Y ACTIVACION INMUNOLOGICA, AGENTES OXIDANTES Y ANTIOXIDANTES Y LAS RESPUESTAS DEL SISTEMA INMUNE. INTOXICACIÓN Y OXIDACIÓN DEL SISTEMA INMUNOLÓGICO.

Simon J. A physiological essay on the thymus gland. London: Ranshaw; 1845: 100.

Beisel WR. Single nutrients and immunity. Am J Clin Nutr 1982; 35: 417-468.

Beisel WR. The history of nutritional immunology. J Nutr Immunol 1991; 1: 62-78.

Chandra RK. Micronutrients and immune functions, an overview. Ann NY Acad Sci 1990; 587: 9-16.

Chandra RK. Nutrition and Immunity. In: Lachmann PJ et al. Clinical aspects of immunology. Boston: Scientific Publications; 1993: 1325-1338.

Chandra RK. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children. BMJ 1975; 2: 583-585.

Bendich A, Chandra RK. Micronutrients and immune function. New York: New York Academy of Sciences; 1990.

Prabhala RH et al. Immunomodulation in humans caused by beta-carotene and vitamin A. Nutr Res 1990; 10: 1473.

Semba RD. Vitamin A, immunity, and infection. Clin Inf Dis 1994; 19: 489-499.

Semba RD. The role of vitamin A and related retinoids in immune function. Nutr Rev 1998; 56: S38-S48.

Chandra RK, Au B. Single nutrient deficiency and cell-mediated immune responses. III. Vitamin A. Nutr Res 1981; 1: 181-185.

Anderson R, et al. Vitamin C and cellular immune functions. In: Bendich A, Chandra RK. Micronutrients and immune function. New York: New York Academy of Sciences 1990: 34-48.

Watson RR et al. Effect of beta-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship. Am J Clin Nutr 1991; 53: 90-94.

Ross AC, Stephenson CB. Vitamin A and retinoids in antiviral responses. FASEB J 1996; 10: 979-985.

Prabhala RH et al. The effects of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans. Cancer 1997; 67: 1556-1560.

Semba RD et al. Abnormal T-cell proportions in vitamin A-deficient children. Lancet 1993; 341: 5-8.

Bendich A, Shapiro SS. Effects of beta-carotene and canthaxanthin on the immune responses of the rat. J Nutr 1996; 116: 2254-2262.

Semba RD et al. Depressed immune response to tetanus in children with vitamin A deficiency. J Nutr 1992; 122: 101-107.

Coutsoudis A, Kiepiela P, Coovadia H, et al. Vitamin A supplementation enhances specific IgG antibody levels and total lymphocyte numbers while improving morbidity in measles. Pediatr Infec Dis J 1992; 11: 203-209.

Meydani SN et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 1990; 52: 557-563.

Meydani SN et al. Vitamin E supplementation enhances in vivo immune response in healthy elderly: a dose-response study. JAMA 1997; 277: 1380-1386.

Bendich A. Antioxidant vitamins and immune responses. In: Chandra RK, Alan R. Nutrition and immunology. New York: Liss., Inc., 1988: 125-147.

Hemila H. vitamin C and infectious diseases. In: Pacler L, Fuchs J. Vitamin C in health and disease. New York: Marcel Dekker, 1997.

Meydani SN et al. Vitamin B-6 deficiency impairs interleukin-2 production and lymphocyte proliferation in elderly adults. Am J Clin Nutr 1991; 53: 1275-1280.

Bendich A, Cohen M. B vitamins: effects on specific and non-specific immune responses. In: Chandra RK, Alan R. Nutrition and immunology. New York: Liss, Inc., 1988: 101-123.

Rotruck JT et al. Selenium: biochemical role as a component of glutathione peroxides. Science 1973; 179: 588-590.

Peretz A et al. Effects of selenium supplementation in immune parameters in gut failure patients on home potential nutrition. Nutrition 1991; 7: 215-221.

Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Nutr 1998; 68: 447S-463S.

Black RE. Therapeutic and preventive effects of zinc on serious chilhood infectious diseases in developing countries. Am J Nutr 1998; 68: 476S-479S.

Chandra RK. Fetal malnutrition and postnatal inmunocompetence. Am J Dis Chil 1975; 125: 450-455.

Chandra RK. Interactions between early nutrition and the immune system. In: Barker DJL, Whelan J. The childhood environment and adult disease. Siba Foundation Symposium # 156. London: Wiley; 1991: 77-88.

Gurr MI. The role of lipids in the regulation of the immune system. Prog Lip Res 1983; 22: 257-287.

Jacob RA, et al. Immunocompetence and oxidant defense during ascarbate depletion of healthy men. Am J Clin Nutr 1991; 54: 1302s-1309s.

2) REFERENCIAS CIENTÍFICAS SOBRE LA EXISTENCIA DE DEFICIENCIAS NUTRICIONALES Y DE AGENTES ANTIOXIDANTES EN PERSONAS SEROPOSITIVAS.

Jain VK, Chandra RD. Does nutritional deficiency predispose to acquired immunodeficiency syndrome? Nutr Res 1984; 4: 537.

Beach RS, Laura PF. Nutrition and the acquired immunodeficiency syndrome. Ann Intern Med 1983; 99: 565-566.

Gray RH. Similarities between AIDS and PCM (Protein Caloric Malnutrition). Amer J Publ Health 1983; 73: 1332.

Keusch GT, Farthing MJG. Nutritional aspects of AIDS. Annu Rev Nutr 1990; 10: 475-501.

Coodley GO. Nutritional deficiency and AIDS. Ann Intern Med 1990; 113: 809.

Bristol-Myers. Malnutrition and the immune response: Focus on cancer and AIDS. Princeton, NJ; 1994; 26.

Raiten DJ. Nutrition and HIV infection: A review and evaluation of the extant knowledge of the relationship between nutrition and HIV infection. FDA Contract No. 223-88-2124; 1990.

Keusch GT, Thea DM. Malnutrition in AIDS. Med Clin NA 1993; 77(4): 795-814.

Beisel WR. AIDS. In: Gershwin ME, German JB, Keen CL. Nutrition and immunology: Principles and practice. Totowa, NJ: Human Press; 2000; 389-402.

Watson RR. Nutrition and AIDS. 2nd Ed. Boca Raton: CRC Press; 2001: 231.

Chelluri L, Jastremski MS. Insidence of malnutrition in patients with acquired immunodeficiency syndrome. Nutr Clin Pract 1989; 4: 16-18.

Coodley GO et al. Micronutrient concentrations in the HIV wasting syndrome. AIDS 1993a; 7: 1595-1600.

Kotler DP et al. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985; 42: 1255-1265.

Chlebowski RT. Significance of altered nutritional status in acquired immune deficiency syndrome (AIDS). Nutr Cancer 1985; 7: 85-91.

Kiure AK, Msamanga GI, Fawzi WW. Nutrition and HIV infection. In: Essex M, Mboup S, Kanki PJ, Marlink RG, Tlou SD. AIDS in Africa. 2nd edition. New York: Kluwer Academic/Plenum Publishers. 2002: 419-435.

Mahan LK, Escott -Stump S. Medical nutritional therapy for human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). In: Food, nutrition, and diet therapy. Philadelphia: W.B. Saunders Company. 2000; 889-911.

Heller L. Nutrition support for children with HIV/AIDS. J Am Diet Assoc 1997; 97: 473.

Melchior JC et al. Resting energy expenditure is increased in stable malnourished HIV-infected patients. Am J Clin Nutr 1991; 53: 437-441.

Ehrenpreis Ed et al. Malabsortion and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis sci 1994; 39: 2159-2162.

Ward BJ et al. Vitamin A status in HIV infection. Nutr Res 1993; 13: 157-166.

Semba RD et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993; 153: 2149-2154.

Semba RD et al. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. JID 1995; 171: 1196-1202.

Karter DL et al. Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a cross-sectional study. J AIDS Hum Retrovirol 1995; 8: 199-203.

3) REFERENCIAS CIENTÍFICAS QUE ADVIERTEN QUE EL PROGRESO DE SEROPOSITIVOS A SIDA, PUEDE SER DEBIDO A DEFICIENCIAS NUTRICIONALES Y DE ANTIOXIDANTES.

Baum MK et al. Micronutrients and HIV-1 disease progression. AIDS 1995; 9: 1051-1056.

Beach RS et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992; 6: 701-708.

Moseson M et al. The potential role of nutritional factors in the induction of immunologic abnormalities in HIV-positive homosexual men. JAIDS 1989; 2: 235-247.

Tang AM et al. Dietary micronutrient intake and risk progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 1993; 138: 1-15.

Bogden JD et al. Micronutrients status and human immunodeficiency virus (HIV) infection. Ann NY Acad Sci 1990; 547: 189-195.

Abrams B et al. A prospective study of dietary intake and AIDS in HIV- seropositive homosexual men. JAIDS 1993; 6: 949-958.

Skurnick JH, et al. Micronutrients profiles in HIV-1-infected heterosexual adults. J Acq Immundef Syndr Hum Retrov 1996; 12: 75-83.

Periquet BA et al. Micronutrient level in HIV-1 infected children. AIDS 1995; 9: 887-893.

Fawzi WW, Hunter DJ. Vitamins in HIV disease progression and vertical transmission. Epidemiology 1998; 9: 457-466.

Castelbon K et al. Nutritional status and dietary intakes in human immunodeficiency virus (HIV)-infected outpatients in Abidjan, Cote d’Ivoire, 1995. Eur J Clin Nutr 1997; 51: 81-86.

Johann-Liang R et al. Energy balance, viral burden, insulin-like growth factor-1, interleukin-6, and growth impairment in children infected with HIV. AIDS 2000; 14: 683-690.

Kotler DP et al. Magnitud of body-cell-mass depletion and the timimg of death from wasting in AIDS. Am J Clin Nutr 1989; 50: 444-447.

Wheeler DA et al. Weight loss as predictor of survival and disease progression in HIV-infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Def Syndr Huma Retrovirol 1998; 18: 80-85.

Feldman JG et al. Serum Albumin as a predictor of survival in HIV-infected women in the Women’s Interagency HIV study. AIDS 2000; 14: 863-870.

Melchior JC et al. Malnutrition and wasting, immunodeficiency, and chronic inflammation as ondependent predictors of survival in HIV-infected patients. Nutrition 1999; 15: 865-869.

Shearer WT et al. Evaluation of immune survival factors in pediatric HIV-1 infection. Ann NY Acad Sci 2000; 918: 298-312.

Semba RD. Vitamin A and HIV infection. Proc Nutr Soc 1997; 56: 459-569.

Fawzi WW et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J 1999; 18: 127-133.

Tang AM et al. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997; 11: 613-620.

Ullrich R et al. Serum carotene deficiency in HIV-infected patients. AIDS 1994; 8: 661-665.

Coutsoudis A et al. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1995; 85: 1076-1081.

Semba RD et al. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. JIF 1994; 171: 1196-1202.

Semba RD. Vitamin A and human immunodeficiency virus infection. Proc Nutr Soc 1997; 56: 1-11.

Landesman S. Vitamin A relationships to mortality in HIV disease and effects on HIV infection: recent and late breaking studies. Presented at forum, Lawton Chiles International House, National Institutes of Health, Bethesda, MD, May 16, 1996.

Tang AM et al. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997; 11: 613-620.

Garewal HS et al. A preliminary trial of beta-carotene in subjects infected with the human immunodeficiency virus. J Nutr 1992; 122: 728-732.

Ullrich R et al. Serum carotene deficiency in HIV-1 infected patients. AIDS 1994; 8: 661-665.

Loya S et al. The carotenoid halocynthiaxanthin: a novel inhibitor of the reverse transcriptase of human immunodeficiency viruses type 1 and type 2. Arch Biochem Biophys 1992; 293: 208-212.

Watson RR et al. Enhanced survival by vitamin A supplentation during retrovirus infection causing murine AIDS. Life Sci 1988; 43: 13-18.

Yang Y et al. Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells. Proc Natl Acad Sci USA 1995; 92: 3051-3055.

Camp WL et al. Serum retinal and HIV-1 RNA viral load in rapid and slow progressors. J Acquir Immune Defic Syndr Hum retroviral 1998; 18: 401-406.

Baum MK et al. Micronutrients and HIV-1 disease progression. AIDS 1995; 9: 1051-1056.

Coodley GO et al. Beta-carotene in HIV infection. J Acquir Immune Defic Syndr 1993; 6: 272-276.

Delmas-Beauvieux MC et al. The enzymatic antioxidant system in blood and glutathione status in HIV-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr 1996; 64: 101-107.

Baum MK et al. HIV-1 infection in women is associated with severe nutritional deficiencies. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 272-278.

Phuapradit W et al. Serum vitamin A and beta-carotene levels in pregnant women infected with HIV-1. Obstet Gynecol 1996; 87: 564-567.

Hussey G et al. Vitamin A status and supplementation and its effects on immunity in children with AIDS. In: Program and abstracts of the XVII international vitamin A consultative group meeting: 1996, Guatemala City, Guatemala. Washington DC: International Life Sciences Institute: pages 6, 81.

Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency virus replication by ascarbate in chronically and acutely infected cell. Proc Natl Acad Sci U.S.A. 1990; 87: 7245-7249.

Harakeh S et al. Mechanistic aspects of ascarbate inhibition of human immunodeficiency virus. Chemico-biological Interactions 1994; 91: 207-215.

Tang AM et al. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997; 11: 613-620.

Wang Y et al. Nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation. J Nutr 1994; 124: 2024-2032.

Wang Y et al. Modulation of immune function and cytokine production by various levels of vitamin E supplementation during murine AIDS. Immunopharmacol 1995; 29: 225-233.

Tang AM et al. Low serum vitamin B12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997; 127: 345-351.

Baum MK et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. JAIDS 1991; 4: 1122-1132.

Haug C et al. Subnormal serum concentration of 1,25 -vitamin D in HIV infection: Correlation with degree of immune deficiency and survival. JID 1994; 169: 889-893.

Baum MK et al. Association of vitamin B-6 status with parameters of immune function in early HIV-1 infection. J AIDS 1991; 4: 1122-1132.

Allard JP et al. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. AIDS 1998; 12: 1653-1659.

Tang AM et al. Dietary micronutrients intake and risk of progression to AIDS in HIV-1-infected homosexual men. Am J Epidemiol 1993; 138: 937-951.

Abrams B et al. A prospective study of dietary intake and AIDS in HIV-seropositive homosexual men J AIDS 1993; 6: 949-958.

Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in HIV-1 infection. Am J Epidemiol 1996; 143: 1244-1256.

Tang AM et al. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997; 11: 613-620.

Tang AM et al. Low serum B-12 concentrations are associated wiuth faster HIV-1 disease progression. J Nutr 1997; 127: 345-351.

Bogden JD et al. Status of selected nutrients and progression of HIV-1 infection. Am J Clin Nutr 2000; 72: 809-815.

Graham NM et al. Relationship of serum cooper and zinc levels to HIV seropositivity and progression to AIDS. J AIDS 1991; 4: 976-980.

Allavena C et al. Relationship of trace elements, immunological markers, and HIV-1 infection progression. Biol Trace Elem Res 1995; 47: 133-138.

Baum MK et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immuno Defic Syndr Hum Retrovirol 1997; 15: 370-374.

4) REFERENCIAS CIENTIFICAS QUE SUSTENTAN LA POSIBILIDAD REAL DE QUE LO QUE SE CONOCE COMO “TRANSMISIÓN DEL SIDA”, PUEDA SER EXPLICADO, EN GRAN PARTE, POR DEFICIENCIAS NUTRICIONALES Y DE AGENTES ANTIOXIDANTES.

Mehendale SM et al. Low carotenoid concentration and the risk of HIV seroconversion in Pune, India. JAIDS 2001; 26: 352-359.

McDonald KS et al. Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 2001; 15: 635-639.

Moore PS et al. Role of nutritional status and weight loss in HIV seroconversion among Rwandan women. JAIDS 1993; 6: 611-616.

Fawzi WW et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. JAIDS 2000; 23: 246-254.

Fawzi WW et al. Randomized trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998; 351: 1477-1482.

Landers DV. 1995 Nutrition and immune function II: Maternal factors influencing transmission. Nutrition in pediatric HIV infection: Setting the research agenda, Bethesda, MD, September 1995.

Stiehm RE. Newborn factors in maternal-infant transmission of pediatric HIV infection. In: Nutrition in pediatric HIV infection: Setting the Research Agenda. Bethesda, MD: NIH, September 1995.

Greenberg BL et al. Vitamin A deficiency and maternal-infant transmission of HIV in two metropolitan areas in the United States. AIDS 1997; 11: 325-332.

Semba RD et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343: 1593-1597.

Phuapradit W et al. Serum vitamin A and betha-carotene levels in pregnant women infected with human immunodeficiency virus-1. Ostet Gynecol 1996; 87: 564-567.

Semba RD et al. Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection. Clin Inf Dis 1995; 21: 966-972.

Coutsoudis A et al. Ramdomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. AIDS 1999; 13: 1517-1524.

Lan Y et al. Carotenoid status of pregnant women with and without HIV infection in Malawi. East Afr Med J 1999; 76: 133-137.

Semba RD et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994a; 343: 1593-1597.

Semba RD et al. Maternal vitamin A deficiency and child growth failure during human immunodeficiency virus infection. JAIDS 1997; 14: 219-222.

Coutsoudis A et al. Effect of vitamin A supplementation on viral load in HIV-1 infected pregnant women. JAIDS 1997; 15: 86-87.

John GC et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. JID 1997; 175: 57-62.

Mostand SB et al. Hormonal concentration, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from cervix and vagina. Lancet 1997; 350: 922-927.

Shah RS et al. Liver stores of vitamin A in human fetuses in relation to gestational age, fetal size and maternal nutritional status. Br J Nutr 1987; 58: 181-189.

Nduati RW et al. Human immunodeficieny virus type-1 infected cells in breast milk: association with immunosuppression and vitamin A deficiency. JID 1995; 172: 1461-1468.

Landesman S. Vitamin A relationships to mortality in HIV disease and effects on HIV infection: recent and late breaking studies. Presented at forum, Lawtom Chiles International House, National Institutes of Health, Bethesda, MD, May 16, 1996.

Graham N et al. Effects of maternal vitamin A deficiency on infant mortality and perinatal HIV transmission. Paper presented at the National Conference on Human Retroviruses and Related Infections: December 12-16, 1993; Baltimore, Maryland, USA.

Mostad SB et akl. Hormonal concentration, vitamin A deficiency, and other risk factors shedding HIV-1 infected cells from cervix and vagina. Lancet 1997; 350: 922-927.

Semba RD et al. HIV load in breast milk, mastitis, and mother-to-child transmission of HIV-1. J Inf Dis 1999; 180: 93-98.

Willumsen JF et al. Subclinical mastitis as a risk factor for mother-infant HIV transmission. Adv Exp Med Biol 2000; 478: 211-223.

5) REFERENCIAS CIENTIFICAS QUE SUSTENTAN LA POSIBILIDAD REAL DE EXPLICAR LA SEROPOSITIVIDAD Y EL SIDA CON ESTRÉS OXIDATIVO. ALGUNAS MEDIDAS DE PREVENCION Y TRATAMIENTO.

Dworkin BM et al. Selenium deficiency in the acquired immunodeficiency syndrome. J Parenteral Enteral Nutr 1986; 10: 405.

Papadopulos-Eleopulos E. Reappraisal of AIDS – Is the oxidation induced by the risk factors the primary cause? Medical Hypothesis 1988; 25: 151-162.

Favier A. The place of oxygen free radicals in HIV infection. A collection of papers presented at a conference on “The place of oxygen free radicals in HIV infection”, Les Deux Alpex, France, January 1993. Chemico-Biological Interactions 1994; 91: 77-224.

Piette et al. Molecular mechanisms of virus activation by free radicals. Collection of 5 articles presented at a conference on “The place of oxygen free radicals in HIV infection” Les Deux Alpes, France, January 1993. Chemico-Biological Interactions 1994; 91: 79-132.

Fuchs J et al. Oxidative imbalance in HIV infected patients. Med Hypothesis 1991; 36: 60-64.

Shallenberger F. Selective compartmental dominance: An explanation for a nonifectious, multifactorial etiology for acquired immune deficiency syndrome (AIDS), and a rationale for ozone therapy and other immune modulating therapies. Med Hypothesis 1998; 50:67-80.

Jarstrand C, Akerlund B. Oxygen radical release by neutrophils of HIV-infected patients. Chemico-Biological Interactions 1994; 91: 141-146.

Salvain B, Mark AW. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leukocyte Biol 1992; 52: 111.

Baruchel S, Wainberg MA. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leukocyte Biol 1992; 51: 111-114.

Polkyov VM et al. Superoxide anion production and enzymatic disbalance in peripheral blood cells isolated from HIV-infected children. Free Radic Biol Med 1994; 16: 15-21.

Hommes MJT et al. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991; 54: 311-315.

Passi S. Progressive increase of oxidative stress in advanced human immunodeficiency. Continuum (London) 1998; 5(4): 20-26.

Favier A et al. Antioxidant status and lipid peroxidation in patients infected with HIV. Chemico-Biological Interactions 1994; 91: 165-180.

Fuchs J et al. Oxidative imbalance in HIV infected patients. Med Hypothesis 1991; 36: 60-64.

Lacey CJ et al. Antioxidant-micronutrients and HIV infection. International J STD & AIDS 1996; 7: 485-489.

Javier JJ et al. Antioxidant micronutrients and immune function in HIV-1 infection. FASEB Proc 1990; 4A: 940-945.

Allard VP et al. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998; 67: 143-147.

Revillard JP, Favier AE, Zittoun M. Lipid peroxidation in human immunodeficiency virus infection. J AIDS 1992; 5: 637-638.

Constants J et al. Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and immunological status. Clinical Biochemistry 1995; 28: 421-426.

Dworkin BM. Selenium deficiency in HIV infection and the aquired immunodeficiency syndrome (AIDS). Chemico-Biological Interactions 1994; 91: 181-186.

Cirelli A et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 1991; 24: 211-214.

Schrauzer GN, Sacher J. Selenium in the maintenance and therapy of HIV-infected patients. Chem Biol Inter 1994; 91: 199.

Simon G et al. Effects of glutathione precursors on huma immunodeficiency virus replication. Chemico-Biological Interactions 1994; 91: 217-224.

Staal FJT et al. Intracellular glutathione levels in T-cells subsets decrease in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe Seyler 1989; 370: 101-108.

Buhl R et al. Systemic glutathion deficiency in symptom-free HIV seropositive individuals. Lancet 1989; ii: 1294-1298.

Dorge W, Eck HL, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction: a rationale for treatment with n-acetyl-cysteine. Immunol Today 1992; 13: 211.

Passi S et al. Study on plasma polyunsaturated fatty acids and vitamin E, and on erythrocyte glutathion peroxidase in highrisk HIV infection categories and AIDS patients. Clin Chem Enzym Comns 1993; 5: 169-177.

Quey B et al. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral n-acetyl-cysteine. AIDS 1992; 5: 814.

Kalevic T et al. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester and N-acetyl-cysteine. Proc Natl Acad Sci U.S.A. 1991; 88: 986

Fabris N et al. AIDS, zinc deficiency and thymic hormone failure. JAMA 1988; 259: 839.

Walter R et al. Zinc status in human immunodeficiency virus infection. Life Sci 1990; 47: 1579.

Falutz J et al. Zinc as a cofactor in HIV-induced immunosuppression. JAMA 1988; 259: 2850-2851.

Graham N et al. Relationship of serum cooper and zinc levels to HIV-1 seropositivity and progression to AIDS. JAIDS 1991; 4: 976-980.

Staal FJT et al. Antioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retroviruses 1993; 9: 299-306.

Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23: 21-48.

Slater TF. Free radicals: formation, detection, reactivity, and citoxicity. In: Lachman PJ, Peters SK, Rosen FS, Walport MJ. Clinical aspects of immunology. Boston: Blackwell Scientific Publications; 1993: 377-393.

Reid L. Oxidative stress and antioxidants. A nutritional perspective. Continuum (London) 1998; 5(3): 52-54.

Papadopulos-Eleopulos E. Looking back on the oxidative stress theory of AIDS. Continuum ( London ) 1998/1999; 5(5): 30-35.

Papadopulos-Eleopulos E, et al. Oxidative stress, HIV and AIDS. Res Immunol 1992; 143: 145-148.

Giraldo RA. Role of free radicals in immunodeficiency. In: Aids and Stressors. Medellín: Impresos Begón; 1997: 72-75.

Slater TF. Free radicals mechanisms in tissue injury. Biochem J 1984; 222: 1-15.

Chandra RK. Nutrition, immunity and infection: present knowledge and future directions. Lancet 1983; i: 688-691.

Giraldo RA. Papel de las enfermedades tropicales en el debilitamiento del sistema inmunolígico y en la fisiopatogénesis del sida. In: Sida y agentes estresantes. Medellín: Editorial Universidad de Antioquia; 2002: 37-46.

McDade TW et al. Prenatal undernutrition is associated with reduced immune function in adolescence. FASEB 2000; 14: A792 (abs.).

Beach RS et al. Gestational zinc deprivation in mice: persistence of immunodeficiency for three generations. Science 1982; 281: 469-471.

Giraldo RA. AIDS and Stressors II: A proposal for the pathogenesis of AIDS. In: AIDS and Stressors. Medellín , Colombia : Impresos Begón ; 1997; 57-96.

Giraldo RA. AIDS and Stressors III: A proposal for the natural history of AIDS. In: AIDS and Stressors. Medellín , Colombia : Impresos Begón ; 1997; 97-131.

Passi S, De Luca C. Dietetic advice for immunodeficiency. Continuum (London) 1998-1999; 5(5): 43-52.

Embid A. Inmunidad aumentada por incremento de micronutrients. Medicinas Complementarias 1994; No. 35: 172.

Embid A. Inmunoterapia a dosis infinitesimales. Medicinas Complementarias 1995; No. 38: 170.

Gerrior J, Wanke C. Nutrition and Immunodeficiency Syndromes. In: Coulston AM, Rock CL, Monsen ER. Nutrition in the prevention and treatment of disease. San Diego: Academic Press; 2001; 741-750.

Life Sciences Research Office, FASEB. Nutritional therapy and nutrition education in the care and management of AIDS patients. Tentative report, Task Order 7. Washington, DC: Center for Food Safety and Nutrition, FDA, DHHS, 1990.

Tang AM et al. Effects of micronutrients intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996; 143: 1244-1256.

Romeyn M. Nutrition and HIV: A new model for treatment. San Francisco : Jossey -Bass Publishers; 1995: 353.

Young J. HIV and medical nutrition therapy. J Amer Diet Assoc 1997; 97: S161.

Collins CL. Nutrition care in AIDS. Diet Curr 1988; 15: 1.

Fenton M, Silverman E. Medical nutritional therapy for human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). In: Mahan K, Escott-Stump S. Krause’s Food, nutrition and diet therapy. Philadelphia: W.B. Saunders Company; 2000: 889-911.

Hickson JF. Diet and nutrition for optimal immune function. In: Bahl SM, Hickson JF. Nutritional care for HIV-positive persons: a manual for individuals and their caregivers. Boca Raton: CRC Press; 1995: 1-36.

Fenton M, Silverman E. Medical nutrition therapy for human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). In: Mahan LK, Escott-Stump S. Food, nutrition, & diet therapy. Philadelphia: W.B. Saunders Company; 2000: 889-911.

American Dietetic Association (ADA). Position of the ADA and the Canadian Dietetic Association: Nutrition intervention in the care of persons with HIV infection. J Am Diet Assoc 1994; 94: 1042.

American Dietetic Association (ADA), HIV/AIDS medical nutrition therapy protocol. Medical nutrition therapy across the continuum of care, 2nd ed. Chicago: ADA, 1998.

Bahl SM, Hickson JF. Nutritional care for HIV-positive persons: A manual for individuals and their caregivers. Boca Raton: CRC Press; 1995: 190.

Bendich A. Role of antioxidants in the maintenance of immune function. In: Frei. Natural antioxidants in human health and disease. (Chapter IV, Immunity and Infection). San Diego: Academic Press; 1994: 447-467.

Bendich A. Antioxidant micronutrients and immunity. In: Roitt IM, Delves PJ. Encyclopedia of immunology. San Diego: Academic Press; 1992: 151-153.

Fishman RHB. Antioxidants and phytotherapy. Lancet 1994: 344: 1356.

Turner VF. Reducing agents and AIDS - Why are we waiting? Med J Austr 1990; 153:502.

Halliwell B, Cross C. Reactive oxygen species, antioxidants and acquired immunodeficiency syndrome. Arch Intern Med 1991; 151: 29-31.

Adam ES. Antioxidant supplementation in HIV/AIDS. Nurse Practit 1995; 20: 8.

Greenspan HC. The role of oxidative oxygen species, antioxidants and phytopharmaceuticals in human immunodeficiency virus activity. Med Hypothesis 1993; 40: 85.

Greenspan HC, Arouma O. Oxidative stress and apoptosis in HIV infection: a role for plant-derived metabolites with synergistic antioxidant activity. Immunol Today 1994; 15: 209.

Greenspan HC, Arouma O. Could oxidative stress initiate programmed cell death in HIV infection? A role for plant derived metabolites having synergistic antioxidant activity. Chemico-Biological Interactions 1994; 91: 187-197.

Tang AM et al. Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. JAIDS 2000; 23: 321-326.

Byrnes SC. Staying on top of oxidative stress. Healthy and Natural Journal, Millenium Wellness Guide 1999. sbyrnes@chaminade.edu. Available in http://www.powerhealth.net.

Zhang Z, Inserra PF, Watson RR. Antioxidants and AIDS. In: Garewal HS. Antioxidants and disease prevention. Boca Raton: CRC Press; 1997; 45-66.

Coodley GO. Beta-carotene therapy in human immunodeficiency virus infection (Abstract). Clin Res 1991; 29: 634A.

Coodley GO et al. Beta-carotene in HIV infection. JAIDS 1993; 272-276.

Coodley et al. Beta-carotene in HIV infection: an extended evaluation. AIDS 1996; 10: 967-973.

Cathart R. Vitamin C in the treatment of acquired immune deficiency syndrome (AIDS). Med Hypothesis 1984: 14: 423.

Clark RH et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methyl butyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. JPEN 2000; 24: 133-139.

Fields-Gardner C. Human immunodeficiency virus infection. In: Matarese LE, Gottschlich MM. Contemporary nutrition support practice: A clinical guide. Philadelphia: Saunders; 2003: 520-532.

Giraldo RA. An effective alternative for the prevention of AIDS. Internet Discussion during the South African Presidential AIDS Advisory Panel, 2000 http://www.robertogiraldo.com/eng/papers/AnEeffectivePreventionForAIDS.html

Giraldo RA. An effective alternative for the treatment of AIDS. Internet Discussion during the South African Presidential AIDS Advisory Panel, 2000. http://www.robertogiraldo.com/eng/papers/AnEffectiveTreatmentForAIDS.html

Giraldo RA, Ródenas P, Flores JJ, Embid A. Tratamiento y prevención del sida: guía de principios básicos para una alternativa no tóxica, efectiva y barata. November 2002 http://www.robertogiraldo.com.html




  Portada     Correo     Artículos     Algunas Referencias      Reportes     English